Skip to content

Effectiveness of Raja Yoga Meditation on Depression, Anxiety and Stress in Females with Premenstrual Syndrome

E. Syamala, P. Roy, K. Sailesh, P. Jabir, U. Madhusudhan, Mukkadan Jk

International Journal of Physiology 2019 DOI: 10.5958/2320-608x.2019.00020.9 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pre-post self-controlled trial Peer reviewed
Sample size 8
Population Females with premenstrual syndrome
Intervention Raja Yoga Meditation
Duration 8-week intervention
Topics Anxiety Depression Meditation
Key findings Raja Yoga Meditation significantly decreased depression, anxiety, and stress scores in females with premenstrual syndrome.

Abstract

The current study was undertaken to observe the effectiveness of Raja Yoga Meditation on depression, anxiety and stress in females with premenstrual syndrome. In the present study, a total of 8 participants were recruited and the participants served as self-controls. After recording the baseline values in premenstrual period (7 days before menstruation) of menstrual cycle, participants were trained Raja yoga meditation for a week days and then they have practiced for once in a day for six days in a week for 8 weeks under the supervision of a trainer. Post-intervention values were recorded after 8 weeks during premenstrual period. The following criteria were used in the selection of the participants. Results were presented in table no 1 and 2. Table no 1 present's demographic data of the participants and table no 2 present's depression, anxiety and stress scores before and after the intervention. There was a significant decrease in the scores of depression, anxiety and stress followed by the meditation (P<0.05). The study provides further evidence for the beneficial effects of practicing Raja yoga meditation in the management of stress. We recommend detailed studies in this area with more parameters and also recommend practicing the meditation in the regular life style.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Explore topics